Indian pharma mulls deal for U.S. injectables maker Sagent Pharma

Emily Wasserman U.S. injectables maker Sagent Pharmaceuticals is considering putting itself on the chopping block, and if or when it does, at least 5 Indian drugmakers could come calling. FiercePharma ...

BioLineRx joins immuno-oncology scrum through Keytruda combo deal

Nick Paul Taylor BioLineRx has become the latest company to stake its claim for a spot on the burgeoning roster of immuno-oncology combinations. The small biotech is aiming to muscle ...

Pfizer CEO: Allergan deal is ‘a lot more about growth’ than job cuts

Carly Helfand Anyone who's examined Pfizer's job-chopping track record knows the company has a tendency to wield the ax in the wake of a megamerger. But this time? Things will ...

Novartis, not to be outdone by respiratory rivals, inks ‘smart inhaler’ deal

Carly Helfand Respiratory drugmakers have been looking to "smart inhaler" technology to give them a leg up on marketing in a crowded field. And Novartis wants a part ...

What’s holding up the Shire-Baxalta deal? One word: Taxes

Carly Helfand Shire and Baxalta both reportedly want to make a tie-up happen. So what's taking so long? According to the Financial Times, the potential deal now hinges ...

Wait for it–Shire could finally announce $32.5B Baxalta deal by Monday

Carly Helfand Could Shire's months-long pursuit of Baxalta finally be coming to a close? That's the word from Reuters, which says the Dublin drugmaker is preparing to announce ...

Single-minded Shire finally pins down Baxalta with $32B deal

Carly Helfand The new year has its first megadeal agreement, thanks to Shire and Baxalta. On Monday, the two finally announced a $ 32 billion tie-up after a months-long pursuit by ...

Landmark $1.9B-plus deal for Seres includes PhIII support

John Carroll FierceBiotech News

Valeant’s big pharmacy deal with Walgreens includes quirky drug-buyback plan

Tracy Staton Valeant Pharmaceuticals' much-ballyhooed agreement with Walgreens includes an unusual inventory provision that helps explain why the pharmacy chain might have been ...

Zoetis hives off 3 manufacturing plants in deal with Bulgarian drugmaker

Tracy Staton Zoetis, under pressure from investors to shape up, laid out a sweeping plan earlier this year to eliminate 10 plants and about 2,500 jobs as part of an effort ...

Shire prepared to walk on Baxalta talks if deal doesn’t come soon: WSJ

Carly Helfand Whether it ends in a tie-up or not, Shire's 6-month pursuit of Baxalta is about to come to a close. That's the word from a Wall Street Journal source close to ...

Valeant strikes price-cutting deal with Walgreens, hoping to polish its tarnished image

Carly Helfand Valeant has been pummeled recently by drug pricing pushback, antitrust allegations and investigations into its business practices. But now, it has a new deal in hand that ...
Page 1 of 1612345...10...Last »
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS